PlumX Metrics
Embed PlumX Metrics

Use of low dose of rFVIIa (recombinant Factor VII activated) to control late bleeding after percutaneous dilational tracheostomy

Clinical Case Reports, ISSN: 2050-0904, Vol: 7, Issue: 4, Page: 665-667
2019
  • 0
    Citations
  • 0
    Usage
  • 8
    Captures
  • 0
    Mentions
  • 41
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

  • Captures
    8
  • Social Media
    41
    • Shares, Likes & Comments
      41
      • Facebook
        41

Article Description

In our case, the use of a low intravenous bolus dose of rFVIIa (recombinant factor VII activated; 15-20 mcg/kg) was effective and uneventful in controlling late postprocedural PDT bleeding associated with thrombocytopenia that cannot be corrected and after all other treatments failed.

Bibliographic Details

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know